scorecardresearch
Add as a preferred source on Google
Sunday, November 2, 2025
TopicMolnupiravir

Topic: Molnupiravir

WHO adds Pfizer’s 2-drug antiviral Paxlovid to Covid recommendations for high-risk patients

WHO Guideline Development Group recommends oral drug Paxlovid for patients with non-severe Covid-19 who are at high risk of hospitalisation.

Panic stockpiling of Molnupiravir can result in similar harm seen last summer. Govt must regulate

ThePrint view on the most important issues, instantly.

Antiviral Molnupiravir not in govt Covid protocol, but ‘millions of doses’ distributed in a week

Pharma companies say doctors working in community settings have begun pre-ordering the drug, several manufacturers gearing up to meet demand.

Week since Molnupiravir was approved for Covid use, few doctors prescribing it, want to wait

Doctors say Molnupiravir may help keep people out of hospitals, but there are concerns about its ability to cause mutation as well as its prescribed dose.

Merck Covid pill raises new hope of reducing hospitalisation & death by up to 50%

Molnupiravir is an oral antiviral medicine meant to be taken by patients soon after symptoms manifest themselves, says Merck citing interim data

On Camera

Shah Rukh Khan’s India is about love, not hate. Chak De! India to My Name Is Khan

This year, Jawan and The Kerala Story both won National Awards. The irony was impossible to miss. One critiqued the system, the other endorsed its narratives. The dichotomy says more about India’s cultural schizophrenia than any film review ever could.

Consumer Price Index gets up to date. Airfare, OTT plans, e-commerce prices in new basket—MoSPI secy

New CPI series will take 2024 as base year, will provide more accurate measure of inflation, spending on digital services. Expected to enhance representation and reliability, says Saurabh Garg.

Joint production, closer ties, emerging tech: The foundation of new defence pact between India & US

The agreement, signed after meeting between Rajnath and US Secretary of War Pete Hegseth on sidelines of ADMM-Plus in Kuala Lumpur, aims to deepen bilateral ties in the critical sector.

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.